Clinical Trial Update: Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics

View source ↗

Summary

This clinical trial update assesses the prevalence of metabolic syndrome among individuals taking antipsychotics, including those with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Schizophrenia

Snippet

Sponsor: Seoul National Hospital | Conditions: Metabolic Syndrome, Schizophrenia | Status: UNKNOWN